Evaluating sustained adherence to ibrutinib in previously treated chronic lymphocytic leukaemia | Dr Jacqueline Barrientos at ASCO 2015
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Jacqueline Barrientos, MD, discusses the results of an analysis that evaluated the effect of a once-daily 420 mg dose of ibruti...
Author: EMJ
Added: 08/25/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts